| For: | de Mattos AA, de Mattos AZ, Manica M, Tovo CV. Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt. World J Hepatol 2025; 17(2): 99809 [PMID: 40027554 DOI: 10.4254/wjh.v17.i2.99809] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i2/99809.htm |
| Number | Citing Articles |
| 1 |
Mingli Jia. Efficacy of prophylactic embolization of spontaneous portosystemic shunts on preoperative CT for post-shunt hepatic encephalopathy in cirrhosis. Journal of Radiation Research and Applied Sciences 2026; 19(3) doi: 10.1016/j.jrras.2026.102553
|
| 2 |
Zhiliang Chen, Yi Gou, Wenke Li, Daowu Yu, Changjie Du, Jue Yuan. Risk factors for recurrent variceal bleeding after TIPS in cirrhotic patients with esophagogastric variceal hemorrhage: a single-center retrospective study. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1951291
|
| 3 |
Weilin Hu, Jinyu Qin, Liming Qiang, Yi Zhang. Risk factors for hepatic encephalopathy in patients following transjugular intrahepatic portosystemic shunt: a meta-analysis and systematic review. BMC Surgery 2026; 26(1) doi: 10.1186/s12893-026-03695-5
|